Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Recruiting · NCT06953180 · Observational (researchers observe without assigning treatment) · Lead sponsor: Asfendiyarov Kazakh National Medical University
View the official record on ClinicalTrials.gov →Interventions studied
Genetic: DNA analysis
What this trial is about
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Who can take part
Age range
18 Years to 69 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adults aged 18 to 69 years.
- Residents of 17 regions of Kazakhstan.
- Willingness to participate and provide informed consent.
Exclusion criteria
- Age less than 18 years old or over 69 years old.
- Failure to provide informed consent or incomplete participation in data collection procedures.
Where it is running
1 location listed.
- Asfendiyarov Kazakh National Medical University - Almaty, Kazakhstan, Kazakhstan